Front Row Advisors LLC Medpace Holdings, Inc. Transaction History

Front Row Advisors LLC

$250 Million
Q1 2025

A detailed history of Front Row Advisors LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Front Row Advisors LLC holds 9,406 shares of MEDP stock, worth $4.21 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

9,406

Previous 9,409 0.03%

Holding current value

$4.21 Million

Previous $3.13 Million 8.32%

% of portfolio

1.15%

Previous 1.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$304.69 - $360.97 $914 - $1,082	-3 Reduced 0.03%	9,406 $2.87 Million
Q4 2024 Feb 12, 2025	BUY	$308.93 - $363.58 $2,780 - $3,272	9 Added 0.1%	9,409 $3.13 Million
Q3 2024 Nov 14, 2024	BUY	$320.58 - $457.29 $36,546 - $52,131	114 Added 1.23%	9,400 $3.13 Million
Q2 2024 Aug 15, 2024	SELL	$372.0 - $424.34 $613,800 - $700,161	-1,650 Reduced 15.09%	9,286 $3.82 Million
Q1 2024 May 14, 2024	SELL	$284.87 - $413.31 $1,424 - $2,066	-5 Reduced 0.05%	10,936 $4.42 Million
Q4 2023 Feb 15, 2024	BUY	$227.52 - $312.68 $4,550 - $6,253	20 Added 0.18%	10,941 $3.35 Million
Q3 2023 Nov 15, 2023	BUY	$233.98 - $281.67 $12,868 - $15,491	55 Added 0.51%	10,921 $2.64 Million
Q2 2023 Aug 14, 2023	SELL	$187.26 - $240.17 $56,927 - $73,011	-304 Reduced 2.72%	10,866 $2.61 Million
Q1 2023 May 22, 2023	BUY	$174.31 - $239.52 $1.58 Million - $2.17 Million	9,069 Added 431.65%	11,170 $2.1 Million
Q1 2023 May 15, 2023	SELL	$174.31 - $239.52 $1.58 Million - $2.17 Million	-9,054 Reduced 81.17%	2,101 $1.12 Million
Q4 2022 Feb 15, 2023	SELL	$153.06 - $226.57 $104,693 - $154,973	-684 Reduced 5.78%	11,155 $2.37 Million
Q3 2022 Nov 15, 2022	BUY	$145.13 - $182.49 $8,707 - $10,949	60 Added 0.51%	11,839 $1.86 Million
Q2 2022 Aug 15, 2022	SELL	$130.2 - $168.03 $1,952 - $2,520	-15 Reduced 0.13%	11,779 $1.76 Million
Q1 2022 May 11, 2022	BUY	$138.87 - $214.31 $136,786 - $211,095	985 Added 9.11%	11,794 $1.93 Million
Q4 2021 Mar 09, 2022	BUY	$182.74 - $227.9 $74,740 - $93,211	409 Added 3.93%	10,809 $2.35 Million
Q3 2021 Nov 03, 2021	BUY	$170.18 - $198.21 $25,527 - $29,731	150 Added 1.46%	10,400 $1.97 Million
Q2 2021 Aug 23, 2021	BUY	$158.62 - $194.3 $112,620 - $137,953	710 Added 7.44%	10,250 $1.81 Million
Q1 2021 Apr 28, 2021	BUY	$132.02 - $168.26 $73,271 - $93,384	555 Added 6.18%	9,540 $1.57 Million
Q4 2020 Feb 25, 2021	SELL	$109.38 - $149.19 $6,562 - $8,951	-60 Reduced 0.66%	8,985 $1.25 Million
Q3 2020 Nov 30, 2020	BUY	$92.95 - $130.61 $6,041 - $8,489	65 Added 0.72%	9,045 $1.12 Million
Q2 2020 Aug 17, 2020	SELL	$68.08 - $95.68 $3,744 - $5,262	-55 Reduced 0.61%	8,980 $835,000
Q1 2020 May 08, 2020	BUY	$61.71 - $101.95 $557,549 - $921,118	9,035 New	9,035 $722,000

Others Institutions Holding MEDP

# of Institutions

632

Shares Held

25.7M

Call Options Held

47K

Put Options Held

80.8K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $13.9B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Account

Front Row Advisors LLC Medpace Holdings, Inc. Transaction History